Daniel Timmermann

Daniel Timmermann is an experienced pharmaceutical executive currently serving as Vice President of E2I Partnership Management at Novo Nordisk since December 2021, where responsibilities include overseeing external collaborations and managing operational and budget support for innovation programs. Prior to this role, Daniel held various leadership positions at Novo Nordisk, including Vice President of Innovation Outreach in Global Drug Discovery and Head of Innovation, contributing significantly to the advancement of treatments for cardiometabolic diseases and rare disorders. Daniel's prior experience also includes senior roles at NeuroSearch, focusing on drug discovery and pharmacology. Daniel holds a PhD in Neuroscience and a Master's in Pharmaceutical Sciences from the University of Copenhagen.